Bright Angel Therapeutics is a developer of novel therapeutics designed to provide treatment of drug-resistant and life-threatening fungal infections. The company's services increases efficacy of current treatments and eradicates drug resistance by targeting the stress responses required by fungi for survival, virulence and drug resistance,enabling users to overcome the frequent emergence of clinical resistance largely responsible for the severe morbidity and mortality associated with infection by diverse fungal pathogens.

Biotechnology

Bright Angel Therapeutics

Bright Angel Therapeutics' headquarters in Toronto, Canada

Dominic Jaikaran

Luke Whitesell

Leah Cowen

Leah Frye

Benjamin Rovinski

Judith Blumstock

Matthew Carlyle

Malik Slassi

Bright Angel Therapeutics

Org chart

Board & advisors

Teams

Offices

Similar companies